BPA Call W91YTZ23A0014-W91YTZ24F0104
Award Date
10/1/23
Potential Completion Date
4/30/24
Potential Value
$9.9K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Cerilliant Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a BPA (Blanket Purchase Agreement) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The contract, valued at $11,104.95, is for the supply of FTDTL (Forensic Toxicology Drug Testing Laboratory) Cerilliant supplies for the Fort Meade location. This BPA call is part of a larger $250,000 DHA BPA that Cerilliant holds to provide drug reference standards through September 2028. Cerilliant, a foreign-owned, for-profit...
Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...
Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
Cerilliant Corporation was awarded a $13,064.06 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide laboratory supplies. The contract has no set-aside designation and runs from the May 19, 2023 award date through the May 19, 2023 completion date. Cerilliant will deliver the requested chemical and biological reference standards and calibrators to support the agency's laboratory programs from their place of performance in Fort Meade, Maryland. No...
This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
<p>Cerilliant Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on April 24, 2023. The potential value of the contract is $2,100 to provide products and services under BPA N-012/N-012 1ML in support of the Defense Health Agency's programs. Performance will take place in Fort Meade, Maryland with an completion date of April 24, 2023. No set-aside designation was used for this award.</p>
Cerilliant Corporation was awarded a $4,912.10 firm fixed price call against the Defense Health Agency's (DHA) CERILLIANT BPA T/O PAIN MANAGEMENT MULTI-COMPONENT blanket purchase agreement (BPA). The contract calls for Cerilliant to provide multi-component pain management products and services in support of DHA programs, with work taking place in Fort Meade, Maryland. No set-aside designation was applied to this award. All work under the contract is scheduled for completion by January 3, 2023.
Cerilliant Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of the Army Medical Command to provide chemical standards in support of forensic drug testing for the Army. With a period of performance through December 2021 and a potential value of $0.00, this BPA call draws from an existing indefinite-delivery/indefinite-quantity contract vehicle to deliver chemicals and standards to the Army's Forensic Toxicology Drug Testing Laboratory...
The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement call contract valued at twenty thousand dollars to Cerilliant Corporation for certified drug reference standards. The contract has a period of performance through August 1, 2022 to support the Medical Command's drug testing and certification programs. Cerilliant will provide reference standards to the Medical Command's laboratories located at Fort Meade, Maryland to assist in their efforts to...